Trump Administration Wants Pharma To Put Prices In Ads, But Experts Are Skeptical That Would Rein In Costs

Experts say drugmakers’ list prices are mostly used as a starting point for negotiations with other health care payers and few patients are asked to pay them, so including may be confusing. HHS Secretary Alex Azar is scheduled to give a speech Monday afternoon that will address the administration’s blueprint for lowering drug costs.

from Kaiser Health News https://ift.tt/2yIQDfo